Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous

Cynthia M Westerhout1, Karen S Pieper, Stefan K James

  • 1Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.

Insights

Dynamic risk models for ST-elevation myocardial infarction (STEMI) show that patient risk changes significantly in the hours after primary percutaneous coronary intervention (PCI). These evolving models improve mortality prediction and aid clinical decisions.

Area of Science:

  • Cardiology
  • Clinical Risk Prediction

Background:

  • Dynamic risk models are crucial for updating the risk profiles of ST-elevation myocardial infarction (STEMI) patients during the acute phase.
  • These models have significant implications for both clinical practice and future research in cardiovascular medicine.

Purpose of the Study:

  • To develop and validate multivariable survival models for predicting 90-day mortality in STEMI patients undergoing primary percutaneous coronary intervention (PCI).
  • To assess how risk profiles and the importance of various clinical factors evolve at different time points (baseline, 2, 24, and 96 hours) post-PCI.

Main Methods:

  • Developed multivariable survival models using data from 5,745 STEMI patients in the APEX-AMI trial.
  • Incorporated factors such as coronary thrombolysis in myocardial infarction flow grade, ST-elevation residual post-PCI, and in-hospital events.
  • Evaluated model performance using the c-index at multiple time points.

Main Results:

  • The 90-day mortality rate was 4.7%, with cumulative mortality occurring by 2, 24, and 96 hours at 8%, 22%, and 40%, respectively.
  • While age and systolic blood pressure remained important, the influence of heart rate, Killip class, and creatinine decreased over time.
  • Markers of coronary reperfusion and in-hospital events like shock and heart failure became increasingly significant predictors.
  • The model's predictive accuracy (c-index) improved from 0.819 at baseline to 0.847 at 96 hours.
  • The proportion of patients classified as "low-risk" (<1.1% 90-day mortality) increased from 20% to 49% over the observed periods.

Conclusions:

  • This novel approach using a series of dynamic models effectively demonstrates the changing nature of mortality risk in STEMI patients post-PCI.
  • The findings highlight the utility of time-varying risk assessment for improving clinical decision-making and patient management.
  • This dynamic risk stratification may enhance understanding of STEMI progression and inform targeted interventions.
Abstract